Literature DB >> 15767084

Group 2A idiopathic juxtafoveolar retinal telangiectasia in monozygotic twins.

Nouman Siddiqui1, Sharon Fekrat.   

Abstract

PURPOSE: To report the clinical and fluorescein angiographic characteristics of monozygotic twins affected by group 2A idiopathic juxtafoveolar retinal telangiectasia.
DESIGN: Observational case report.
METHODS: Both eyes of identical twins were examined in a clinical practice setting.
RESULTS: Two 68-year-old Caucasian, monozygotic, female twins were examined. In one twin, visual acuity was 20/50 in the right eye (OD) and 20/40 in the left (OS). Ophthalmoscopy demonstrated right-angle venules without edema in both eyes (OU). Fluorescein angiography demonstrated areas of leakage temporal to the fovea OU with some nasal leakage OS. In her identical twin sister, with type II diabetes, visual acuity was 20/60 OD and 20/25 OS. Right-angle venules OU, refractile deposits OS, and no macular edema OU were present. Fluorescein angiography demonstrated areas of parafoveal leakage temporal and nasal OD and temporal OS.
CONCLUSION: This is the second set of female monozygotic twins with group 2A idiopathic juxtafoveolar retinal telangiectasia reported in the literature. This finding suggests a genetic component in the pathogenesis of this retinal vascular disease.

Entities:  

Mesh:

Year:  2005        PMID: 15767084     DOI: 10.1016/j.ajo.2004.09.030

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  12 in total

1.  Idiopathic juxtafoveolar retinal telangiectasis in monozygotic twins.

Authors:  Shabeeba R Hannan; Krishnappa C Madhusudhana; Christina Rennie; Andrew J Lotery
Journal:  Br J Ophthalmol       Date:  2007-12       Impact factor: 4.638

2.  Genome-wide analyses identify common variants associated with macular telangiectasia type 2.

Authors:  Thomas S Scerri; Anna Quaglieri; Carolyn Cai; Jana Zernant; Nori Matsunami; Lisa Baird; Lea Scheppke; Roberto Bonelli; Lawrence A Yannuzzi; Martin Friedlander; Catherine A Egan; Marcus Fruttiger; Mark Leppert; Rando Allikmets; Melanie Bahlo
Journal:  Nat Genet       Date:  2017-02-27       Impact factor: 38.330

3.  The prevalence of macular telangiectasia type 2 in the Beaver Dam eye study.

Authors:  Ronald Klein; Barbara A Blodi; Stacy M Meuer; Chelsea E Myers; Emily Y Chew; Barbara E K Klein
Journal:  Am J Ophthalmol       Date:  2010-07       Impact factor: 5.258

4.  Analysis of glutathione S-transferase Pi isoform (GSTP1) single-nucleotide polymorphisms and macular telangiectasia type 2.

Authors:  Joshua A Szental; Paul N Baird; Andrea J Richardson; F M Amirul Islam; Hendrik P N Scholl; Peter Charbel Issa; Frank G Holz; Mark Gillies; Robyn H Guymer
Journal:  Int Ophthalmol       Date:  2010-05-25       Impact factor: 2.031

5.  Idiopathic juxtafoveolar retinal telangiectasis: a current review.

Authors:  Sawsan R Nowilaty; Hanan N Al-Shamsi; Wajeeha Al-Khars
Journal:  Middle East Afr J Ophthalmol       Date:  2010-07

Review 6.  Macular telangiectasia type 2.

Authors:  Peter Charbel Issa; Mark C Gillies; Emily Y Chew; Alan C Bird; Tjebo F C Heeren; Tunde Peto; Frank G Holz; Hendrik P N Scholl
Journal:  Prog Retin Eye Res       Date:  2012-12-03       Impact factor: 21.198

7.  Familial asymptomatic macular telangiectasia type 2.

Authors:  Mark C Gillies; Meidong Zhu; Emily Chew; Daniel Barthelmes; Edward Hughes; Haipha Ali; Frank G Holz; Hendrik P N Scholl; Peter Charbel Issa
Journal:  Ophthalmology       Date:  2009-10-07       Impact factor: 12.079

8.  CONCURRENT IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 AND CENTRAL SEROUS CHORIORETINOPATHY.

Authors:  Alexandre Matet; Suzanne Yzer; Emily Y Chew; Alejandra Daruich; Francine Behar-Cohen; Richard F Spaide
Journal:  Retina       Date:  2018-01       Impact factor: 4.256

9.  Optical coherence tomography findings in idiopathic juxtafoveal retinal telangiectasis.

Authors:  Vladimir Surguch; Maria-Andreea Gamulescu; Veit-Peter Gabel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-11-22       Impact factor: 3.535

10.  Identification of a potential susceptibility locus for macular telangiectasia type 2.

Authors:  Nancy L Parmalee; Carl Schubert; Maria Figueroa; Alan C Bird; Tunde Peto; Mark C Gillies; Paul S Bernstein; Krzysztof Kiryluk; Joseph D Terwilliger; Rando Allikmets
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.